U.S. feds launch probe into AstraZeneca plant in U.K.

Eric Palmer U.S. federal investigators have taken an interest in manufacturing at an AstraZeneca ($ AZN) plant in England, but the company is remaining mum about what precisely they ...

Cipla steamrolls into Enbrel market with biosimilar of Amgen drug

Tracy Staton While the FDA continues its slow-motion release of new guidelines for producing biosimilars in the U.S., India's Cipla has stepped up with a knockoff of the rheumatoid ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS